Gp120 modulates the biology of human hepatic stellate cells: A link between HIV infection and liver fibrogenesis

Gut

Volumn 59, Issue 4, 2010, Pages 513-520

  Bruno, Raffaele ^a   Galastri, Sara ^b   Sacchi, Paolo ^a   Cima, Serena ^a   Caligiuri, Alessandra ^b   DeFranco, Raffaella ^b   Milani, Stefano ^b   Gessani, Sandra ^c   Fantuzzi, Laura ^c   Liotta, Francesco ^b   Frosali, Francesca ^b   Antonucci, Giorgio ^d   Pinzani, Massimo ^b   Marra, Fabio ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; PROTEIN KINASE B; RECOMBINANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CELL ISOLATION; CELL MIGRATION; CHEMOTAXIS; FIBROGENESIS; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MIXED INFECTION; NORMAL HUMAN; PATHOGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL;

CELLS, CULTURED; CHEMOKINE CCL2; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATIC STELLATE CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECOMBINANT PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 77950814587     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.163287     Document Type: Article

References (43)

1. Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol 2008;48:353-367
2. Bonacini M. Diagnosis and management of cirrhosis in coinfected patients. J Acquir Immune Defic Syndr 2007;45:S38-46; discussion S66-7.
3. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669
4. Marra F, Valente AJ, Pinzani M, et al. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest 1993;92:1674-1680 (Pubitemid 23304529)
5. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172
6. Bataller R, Paik YH, Lindquist JN, et al. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 2004;126:529-540 (Pubitemid 38182310)
7. Mazzocca A, Sciammetta SC, Carloni V, et al. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J Biol Chem 2005;280:11329-11339 (Pubitemid 40418440)
8. Schulze-Krebs A, Preimel D, Popov Y, et al. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 2005;129:246-258 (Pubitemid 41002058)
9. Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000;14:2709-2713 (Pubitemid 32118724)
10. Oh SK, Cruikshank WW, Raina J, et al. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 1992;5:251-256
11. Casini A, Pinzani M, Milani S, et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology 1993;105:245-253 (Pubitemid 23234043)
12. Marra F, Choudhury GG, Abboud HE. Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis. J Clin Invest 1996;98:1218-1230 (Pubitemid 26299935)
13. Caligiuri A, Bertolani C, Guerra CT, et al. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology 2008;47:668-676 (Pubitemid 351280735)
14. Bonacchi A, Romagnani P, Romanelli RG, et al. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 2001;276:9945-9954 (Pubitemid 37391899)
15. Efsen E, Bonacchi A, Pastacaldi S, et al. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 2001;33:713-721 (Pubitemid 32185235)
16. Romagnani P, Annunziato F, Liotta F, et al. CD14+ CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322 (Pubitemid 41216135)
17. Marra F, DeFranco R, Grappone C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998;152:423-430 (Pubitemid 28106388)
18. Hong F, Tuyama A, Agarwal R, et al. Autocrine signaling by SDF-1alpha through its receptor, CXCR4, mediates hepatic stellate cell activation in vivo and in vitro. Hepatology 2007;46:867A.
19. Schwabe RF, Bataller R, Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 2003;285:G949-58.
20. Marra F, Gentilini A, Pinzani M, et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology 1997;112:1297-1306 (Pubitemid 27157544)
21. Yang C, Zeisberg M, Mosterman B, et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003;124:147-159 (Pubitemid 36055348)
22. Fantuzzi L, Canini I, Belardelli F, et al. HIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J Immunol 2001;166:5381-5387 (Pubitemid 32374157)
23. Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci 2002;7:d1899-914.
24. Bonacchi A, Petrai I, Defranco RM, et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003;125:1060-1076 (Pubitemid 37193453)
25. Marra F, Delogu W, Petrai I, et al. Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2004;287:G18-26. (Pubitemid 38802114)
26. Thirunavukkarasu C, Watkins SC, Gandhi CR. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology 2006;44:389-398
27. Baba M, Nishimura O, Kanzaki N, et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 1999;96:5698-5703 (Pubitemid 29234681)
28. Dragic T, Trkola A, Thompson DA, et al. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci USA 2000;97:5639-5644 (Pubitemid 30313771)
29. Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 2002;37:527-535
30. Munshi N, Balasubramanian A, Koziel M, et al. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 2003;188:1192-1204 (Pubitemid 37338984)
31. Petrovic LM. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article. Liver Int 2007;27:598-606.
32. Czaja MJ, Geerts A, Xu J, et al. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol 1994;55:120-126 (Pubitemid 24039594)
33. Del Corno M, Liu QH, Schols D, et al. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 2001;98:2909-2916
34. Davis CB, Dikic I, Unutmaz D, et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997;186:1793-1798 (Pubitemid 27506294)
35. Liu QH, Williams DA, McManus C, et al. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc Natl Acad Sci USA 2000;97:4832-4837 (Pubitemid 30238643)
36. Romagnani P, Annunziato F, Lasagni L, et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001;107:53-63. (Pubitemid 32047414)
37. Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 2003;278:35755-35766 (Pubitemid 37102352)
38. Fantuzzi L, Spadaro F, Purificato C, et al. Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-κB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages. Blood 2008;111:3355-3363
39. Kuntzen T, Tural C, Li B, et al. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. AIDS 2008;22:203-210
40. Benhamou Y, Di Martino V, Bochet M, et al. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 2001;34:283-287 (Pubitemid 32702341)
41. Qurishi N, Kreuzberg C, Luchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003;362:1708-1713 (Pubitemid 37468321)
42. Sitia G, De Bona A, Bagaglio S, et al. Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy. Antivir Ther 2006;11:385-389 (Pubitemid 43823558)
43. Kuhmann SE, Hartley O. Targeting chemokine receptors in HIV: a status report. Annu Rev Pharmacol Toxicol 2008;48:425-461 (Pubitemid 351738160)